Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon Zugazagoitia

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2022
Extensive-Stage Small-Cell Lung Cancer: First-Line and Second-Line Treatment OptionsJon Zugazagoitia, Luis Paz-Ares
The Lancet. Oncology|October 19, 2016
Osimertinib in EGFR-mutant NSCLC: how to select patients and when to treatJon Zugazagoitia, Irene Ferrer, Luis Paz-Ares
Translational Lung Cancer Research|March 10, 2016
Necitumumab for first-line treatment of advanced, squamous, non-small-cell lung cancer: a relevant step forward?Jon Zugazagoitia, Santiago Ponce, Luis Paz-Ares
Expert Opinion on Drug Metabolism & Toxicology|July 21, 2018
Necitumumab: a new option for first-line treatment of squamous cell lung cancerElizabeth Jiménez Aguilar, Jon Zugazagoitia Fraile, Luis Paz-Ares Rodríguez
Nature Reviews. Clinical Oncology|January 13, 2023
At the crossroads of immunotherapy for oncogene-addicted subsets of NSCLCItziar Otano, Alvaro C Ucero, Jon Zugazagoitia, et al.
Journal of Cancer Research and Therapeutics|July 31, 2012
Severe perirenal hematoma in a patient with a single kidney treated with sunitinib for metastatic pancreatic neuroendocrine tumorJon Zugazagoitia, Javier Sastre, Jerónimo Barrera, et al.
The European Respiratory Journal|March 4, 2017
Biological therapies in nonsmall cell lung cancerJon Zugazagoitia, Sonia Molina-Pinelo, Fernando Lopez-Rios, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 7, 2020
Digital quantitative assessment of PD-L1 using digital spatial profilingSwati Gupta, Jon Zugazagoitia, Sandra Martinez-Morilla, et al.
Journal of Thoracic Disease|October 29, 2014
The new IASLC/ATS/ERS lung adenocarcinoma classification from a clinical perspective: current concepts and future prospectsJon Zugazagoitia, Ana Belen Enguita, Juan Antonio Nuñez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2024
Facts and Hopes on Cancer Immunotherapy for Small Cell Lung CancerJon Zugazagoitia, Handerson Osma, Javier Baena, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2022
Extensive-Stage Small-Cell Lung Cancer: First-Line and Second-Line Treatment OptionsJon Zugazagoitia, Luis Paz-Ares
The Lancet. Oncology|October 19, 2016
Osimertinib in EGFR-mutant NSCLC: how to select patients and when to treatJon Zugazagoitia, Irene Ferrer, Luis Paz-Ares
Translational Lung Cancer Research|March 10, 2016
Necitumumab for first-line treatment of advanced, squamous, non-small-cell lung cancer: a relevant step forward?Jon Zugazagoitia, Santiago Ponce, Luis Paz-Ares
Expert Opinion on Drug Metabolism & Toxicology|July 21, 2018
Necitumumab: a new option for first-line treatment of squamous cell lung cancerElizabeth Jiménez Aguilar, Jon Zugazagoitia Fraile, Luis Paz-Ares Rodríguez
Nature Reviews. Clinical Oncology|January 13, 2023
At the crossroads of immunotherapy for oncogene-addicted subsets of NSCLCItziar Otano, Alvaro C Ucero, Jon Zugazagoitia, et al.
Journal of Cancer Research and Therapeutics|July 31, 2012
Severe perirenal hematoma in a patient with a single kidney treated with sunitinib for metastatic pancreatic neuroendocrine tumorJon Zugazagoitia, Javier Sastre, Jerónimo Barrera, et al.
The European Respiratory Journal|March 4, 2017
Biological therapies in nonsmall cell lung cancerJon Zugazagoitia, Sonia Molina-Pinelo, Fernando Lopez-Rios, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 7, 2020
Digital quantitative assessment of PD-L1 using digital spatial profilingSwati Gupta, Jon Zugazagoitia, Sandra Martinez-Morilla, et al.
Journal of Thoracic Disease|October 29, 2014
The new IASLC/ATS/ERS lung adenocarcinoma classification from a clinical perspective: current concepts and future prospectsJon Zugazagoitia, Ana Belen Enguita, Juan Antonio Nuñez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2024
Facts and Hopes on Cancer Immunotherapy for Small Cell Lung CancerJon Zugazagoitia, Handerson Osma, Javier Baena, et al.
Pageof 8